Tripeptidyl Peptidase II Is Required for c-MYC-Induced Centriole Overduplication and a Novel Therapeutic Target in c-MYC-Associated Neoplasms
about
Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency.Novel protein-protein interactions of TPPII, p53, and SIRT7.The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging.Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2.A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers.Brief report: chimeric pigs produced from induced pluripotent stem cells demonstrate germline transmission and no evidence of tumor formation in young pigs.
P2860
Tripeptidyl Peptidase II Is Required for c-MYC-Induced Centriole Overduplication and a Novel Therapeutic Target in c-MYC-Associated Neoplasms
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@en
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@nl
type
label
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@en
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@nl
prefLabel
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@en
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@nl
P2093
P2860
P356
P1433
P1476
Tripeptidyl Peptidase II Is Re ...... in c-MYC-Associated Neoplasms
@en
P2093
Anette Duensing
Anthony G Brickner
Nadja Melquiot
Rolando Cuevas
Sebastian Darr
Stefan Duensing
P2860
P304
P356
10.1177/1947601910389605
P50
P577
2010-09-01T00:00:00Z